Myriad’s True Value

Some interesting points raised in a NY Times editorial yesterday regarding Myriad’s true underlying value being in its database of mutations. In a paper referenced by the editorial the authors describe Myriad’s database of BRCA1/2 mutations and the value...

Reporting rates for clinical trials

Unmasking ‘Invisible’ Drug Trials – ScienceInsider. Do drug companies and other commercial entities have an obligation to report the results of the clinical trials they have sponsored? Interesting question, that. Most trials for novel therapeutics...

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access